Bringing Patient Biology into Early Drug Development | Oncode Accelerator
Cumulus Oncology strengthens its leadership with new appointments to the Board of Directors and Scientific Advisory Team.
Bioworld: Cumulus raising $50M, spinning GPR68 small molecules into GIO
Cumulus Oncology Ltd. is in the thick of raising a $50 million series A round as its model of sourcing novel drug targets emerging from academia, shaping them up for clinical development, and spinning them into startups, gathers pace.